Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
Clinical trial NCT02437318 · COMPLETED
Trial details
- NCT number
- NCT02437318
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-23
- Primary completion
- 2018-06-12
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.